Food and Drug Administration Commissioner Scott Gottlieb said his agency has plans to regulate CBD edibles and will start holding public hearings on the matter as early as April.
The FDA has taken notice of the legalization of hemp and CBD in December, Gottlieb said during a Wednesday House Appropriations Committee committee.
The agency is assembling a team of senior officials to develop new rules and will start the process with a public hearing in April.
Gottlieb also warned the committee that the regulations concerning CBD-infused food products will not be straightforward. As a potential pathway, Gottlieb said the FDA might regulate products with high CBD content as drugs and subject them to more stringent rules, but products with lower concentrations could be categorized as food products.
Why It's Important
Since the legalization of hemp and hemp-derived CBD in the Farm Bill, the CBD industry has eyed the FDA's position toward the substance, as it represents an obstacle to mass-market CBD edibles from a federal standpoint.
A clear set of rules would make it easier for companies like New Age Beverages Corp (NASDAQ: NBEV) to distribute their products and would eliminate the uncertainties that might prevent large retailers such as Walmart, Inc. (NYSE: WMT), from offering CBD products.
Martha Stewart Joins Canopy Growth In Advisory Role To Develop CBD Product Line
Cannex Capital Enters CBD Market Through Pure Ratios Holdings Acquisition
Public domain photo via Wikipedia.
See more from Benzinga
- Martha Stewart Joins Canopy Growth In Advisory Role To Develop CBD Product Line
- Cantor Reiterates Bullish View On GW Pharmaceuticals Following Earnings
- Valens GroWorks To Supply Tilray With Cannabis, Hemp Extracts
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.